Role of Dietary Fats in Modulating Cardiometabolic Risk During Moderate Weight Gain: A Randomized Double‐Blind Overfeeding Trial (LIPOGAIN Study)
Open Access
- 16 September 2014
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 3 (5) , e001095
Abstract
Background: Whether the type of dietary fat could alter cardiometabolic responses to a hypercaloric diet is unknown. In addition, subclinical cardiometabolic consequences of moderate weight gain require further study. Methods and Results: In a 7‐week, double‐blind, parallel‐group, randomized controlled trial, 39 healthy, lean individuals (mean age of 27±4) consumed muffins (51% of energy [%E] from fat and 44%E refined carbohydrates) providing 750 kcal/day added to their habitual diets. All muffins had identical contents, except for type of fat; sunflower oil rich in polyunsaturated fatty acids ( PUFA diet) or palm oil rich in saturated fatty acids ( SFA diet). Despite comparable weight gain in the 2 groups, total: high‐density lipoprotein ( HDL ) cholesterol, low‐density lipoprotein: HDL cholesterol, and apolipoprotein B: AI ratios decreased during the PUFA versus the SFA diet (−0.37±0.59 versus +0.07±0.29, −0.31±0.49 versus +0.05±0.28, and −0.07±0.11 versus +0.01±0.07, P =0.003, P =0.007, and P =0.01 for between‐group differences), whereas no significant differences were observed for other cardiometabolic risk markers. In the whole group (ie, independently of fat type), body weight increased (+2.2%, P P =0.007), insulin (+17%, P =0.003), proprotein convertase subtilisin/kexin type 9, (+9%, P =0.008) fibroblast growth factor‐21 (+31%, P =0.04), endothelial markers vascular cell adhesion molecule–1, intercellular adhesion molecule–1, and E‐selectin (+9, +5, and +10%, respectively, P P =0.001). Conclusions: Excess energy from PUFA versus SFA reduces atherogenic lipoproteins. Modest weight gain in young individuals induces hyperproinsulinemia and increases biomarkers of endothelial dysfunction, effects that may be partly outweighed by the lipid‐lowering effects of PUFA . Clinical Trial Registration: URL : http://ClinicalTrials.gov . Unique identifier: NCT 01427140.Keywords
This publication has 42 references indexed in Scilit:
- SFAs do not impair endothelial function and arterial stiffnessThe American Journal of Clinical Nutrition, 2013
- RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean DietNew England Journal of Medicine, 2013
- Cardiovascular risk escalation with caloric excess: a prospective demonstration of the mechanics in healthy adultsCardiovascular Diabetology, 2013
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation studyThe Lancet, 2012
- Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in HumansPLOS ONE, 2012
- Components of a Cardioprotective DietCirculation, 2011
- The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?The American Journal of Clinical Nutrition, 2011
- Short-Term Overfeeding May Induce Peripheral Insulin Resistance Without Altering Subcutaneous Adipose Tissue Macrophages in HumansDiabetes, 2010
- Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPLOS Medicine, 2010
- Large Artery Stiffening With Weight Gain in HumansHypertension, 2008